Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cashflow Statement

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,189 Cr₹1,114 Cr₹745 Cr₹909 Cr₹900 Cr
Adjustment ₹112 Cr₹83 Cr₹131 Cr₹92 Cr₹115 Cr
Changes In working Capital ₹179 Cr₹-100 Cr₹67 Cr₹-200 Cr₹-209 Cr
Cash Flow after changes in Working Capital ₹1,480 Cr₹1,097 Cr₹943 Cr₹801 Cr₹807 Cr
Cash Flow from Operating Activities ₹1,157 Cr₹785 Cr₹792 Cr₹562 Cr₹576 Cr
Cash Flow from Investing Activities ₹-377 Cr₹65 Cr₹-560 Cr₹-74 Cr₹-282 Cr
Cash Flow from Financing Activities ₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr
Net Cash Inflow / Outflow ₹47 Cr₹-201 Cr₹124 Cr₹28 Cr₹-24 Cr
Opening Cash & Cash Equivalents ₹129 Cr₹330 Cr₹206 Cr₹178 Cr₹202 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹177 Cr₹129 Cr₹331 Cr₹205 Cr₹178 Cr

Compare Cashflow Statement of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,625.9 Cr 2.3% -0% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.3%

-0%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses